Advertisement Medivir names Maris Hartmanis as CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Medivir names Maris Hartmanis as CEO

Medivir, a Sweden-based developer of pharmaceuticals against infectious diseases, has named Maris Hartmanis as new president and CEO.

Hartmanis held leadership positions in Gambro, Amersham and Pharmacia and was appointed as CEO of the specialty pharmaceutical company BioPhausia in 2010.

Medivir chairman of the board Goran Pettersson said through the appointment of Maris Hartmanis as CEO, they secure an appropriate succession of the leadership of Medivir and a continued positive development of Medivir as a research-based specialty pharmaceutical company.